Science Explorer Interactive view Map
Hospital / health system · Nashville · United States

Tennessee Oncology

In research, Tennessee Oncology stands highest in Medicine (#4,537 of 10,443 worldwide) and Health Sciences (#5,652 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Oncology — Oncology is 20.6× its share of world research.

World rank, 2022–2025
#9,542
of 28,054 · #10,978 all time
Rank in United States
#1,279
of 4,192
Research works
601
▲ 42% vs 2013–17
Citations
21k
34.9 per fractional work
Top-10% rate
21.0%
record average 16.5%
Open access
30%
world 28%

What is Tennessee Oncology known for in research?

The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
MedicineField #4,537 of 10,443 23.0%96 #3020
Health SciencesDomain #5,652 of 11,982 22.8%101 #4065

Each strip is that field’s whole ranked pool, with the notch where Tennessee Oncology sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

What does Tennessee Oncology specialise in?

Where its research is concentrated relative to its size: Oncology takes 20.6× the share of its output that it takes of world research.

  1. OncologySubfield · 34.2 works21×
← less than its size predictsmore →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.03× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.07× its world share, 24 worksBiochemistry, Geneti…Immunology and Microbiology: 3.38× its world share, 5 worksImmunology and Micro…Neuroscience: 0.32× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.45× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.27× its world share, 1 worksChemistryComputer Science: 0.05× its world share, 1 worksComputer ScienceEngineering: 0.05× its world share, 1 worksEngineeringMaterials Science: 0.07× its world share, 0 worksMaterials ScienceMathematics: 0.09× its world share, 0 worksMathematicsPhysics and Astronomy: 0.32× its world share, 1 worksPhysics and AstronomyDentistry: 1.20× its world share, 1 worksDentistryHealth Professions: 0.93× its world share, 4 worksHealth ProfessionsMedicine: 3.37× its world share, 96 worksMedicineNursing: 0.77× its world share, 1 worksNursingBusiness, Management and Accounting: 0.28× its world share, 1 worksBusiness, Management…Decision Sciences: 0.11× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 3.19× its world share, 10 worksEconomics, Econometr…Social Sciences: 0.05× its world share, 1 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Immunology and Microbiology, 3.4×. Every wedge is a field page.

Who are the top researchers at Tennessee Oncology?

Ranked on the composite score, Davey B. Daniel, J. R. Infante and Todd M. Bauer lead among researchers whose main affiliation is Tennessee Oncology.

  1. 1 Davey B. Daniel United States · #85,697 worldwide 312 citations · 27 works
  2. 2 J. R. Infante United States · #213,837 worldwide 98 citations · 27 works
  3. 3 Todd M. Bauer United States · #781,984 worldwide 141 citations · 82 works
All ranked researchers at Tennessee Oncology

Which keywords describe research at Tennessee Oncology?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Immunotherapy, Targeted Therapy, Clinical Trials, Breast Cancer, Prognostic Factors, Tumor Microenvironment and Lymphoma.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Chemotherapy19▲ 18×22 topics
  2. Immunotherapy16▲ 16×15 topics
  3. Targeted Therapy16▲ 48×5 topics
  4. Clinical Trials13▲ 13×10 topics
  5. Breast Cancer12▲ 34×11 topics
  6. Prognostic Factors11▲ 17×12 topics
  7. Tumor Microenvironment9▲ 14×8 topics
  8. Lymphoma9▲ 36×3 topics
  9. Quality of Life8▲ 3.7×11 topics
  10. Cancer Immunotherapy8▲ 34×3 topics
  11. Metastatic Breast Cancer8▲ 92×2 topics
  12. Tumor Regression7▲ 45×2 topics
  13. Radiotherapy7▲ 13×10 topics
  14. Genomic Profiling7▲ 45×2 topics
  15. Treatment Guidelines6▲ 20×2 topics
  16. ALK Inhibitors6▲ 70×1 topic
  17. EGFR Mutations6▲ 70×1 topic
  18. Metastasis6▲ 13×10 topics
  19. Precision Medicine6▲ 9.3×6 topics
  20. Cost of Care6▲ 136×1 topic
  21. Financial Toxicity6▲ 136×1 topic
  22. Leukemia6▲ 48×2 topics
  23. CAR T Cells6▲ 55×1 topic
  24. Chimeric Antigen Receptor6▲ 55×1 topic
  25. Rituximab6▲ 26×2 topics
  26. Biomarkers5▲ 5.2×7 topics
  27. Genomic Instability5▲ 33×3 topics
  28. PET Imaging5▲ 21×4 topics
  29. Cancer Therapy5▲ 6.2×14 topics
  30. Cell Cycle Control5▲ 116×2 topics
  31. CDK4/6 Inhibitors5▲ 138×1 topic
  32. Metastatic5▲ 55×2 topics
  33. Palbociclib5▲ 138×1 topic
  34. Immune Checkpoint Blockade5▲ 30×1 topic
  35. PD-1 and PD-L15▲ 30×1 topic
  36. Cancer Genomics5▲ 44×1 topic
  37. Mutational Signatures5▲ 44×1 topic
  38. Monoclonal Antibody5▲ 59×2 topics
  39. EGFR4▲ 97×1 topic
  40. Trastuzumab4▲ 61×2 topics

Which research topics does Tennessee Oncology publish most on?

By volume in 2022–2025: Lung Cancer Treatments and Mutations, Economic and Financial Impacts of Cancer, CAR-T cell therapy research and Advanced Breast Cancer Therapies.

  1. 1 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 6 works
  2. 2 Economic and Financial Impacts of Cancer Economics and Econometrics 6 works
  3. 3 CAR-T cell therapy research Oncology 6 works
  4. 4 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 5 works
  5. 5 Cancer Immunotherapy and Biomarkers Oncology 5 works
  6. 6 Cancer Genomics and Diagnostics Cancer Research 5 works
  7. 7 HER2/EGFR in Cancer Research Oncology 4 works
  8. 8 Lung Cancer Research Studies Oncology 4 works
  9. 9 Chronic Lymphocytic Leukemia Research Genetics 3 works
  10. 10 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 3 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available29.5%not open70.5%

World: 28% of research is openly available.

with international co-authors28.2%domestic only71.8%

World: 19% is written across borders.

How has Tennessee Oncology's research output changed?

Output in 2018–2022 was 42% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Nashville

All research institutions in Nashville

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.